American Heart Journal
Volume 146, Issue 2 , Pages 234-241 , August 2003

Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the danish trial in acute myocardial infarction-2 (DANAMI-2)

  • Henning Rud Andersen, MD

      Affiliations

    • Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark
    • Corresponding Author InformationReprint requests: Henning Rud Andersen, MD, Department of Cardiology B, Skejby Sygehus, Aarhus University Hospital, Brendstrupgaardsvej, DK-8200, Aarhus N, Denmark.
    • ,
  • Torsten Toftegaard Nielsen, MD

      Affiliations

    • Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Thomas Vesterlund, MD

      Affiliations

    • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
    • ,
  • Peer Grande, MD

      Affiliations

    • The Heart Center, Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark
    • ,
  • Ulrik Abildgaard, MD

      Affiliations

    • Department of Cardiology, Gentofte Hospital, Hellerup, Denmark
    • ,
  • Per Thayssen, MD

      Affiliations

    • Department of Cardiology, Odense University Hospital, Odense, Denmark
    • ,
  • Flemming Pedersen, MD

      Affiliations

    • Department of Medicine, Hilleroed Hospital, Hilleroed, Denmark
    • ,
  • Leif Spange Mortensen, MSc

      Affiliations

    • UNI-C, Danish IT Centre for Education and Research, Aarhus, Hilleroed, Denmark
    • ,
  • DANAMI-2 Investigators

Received 29 April 2003 ,Accepted 12 May 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by grants from the Danish Heart Foundation, The Danish Medical Research Council, Astra-Zeneca, Bristol-Myers Squibb, Cordis, a Johnson & Johnson Company, Pfizer, Pharmacia-Upjohn, Boehringer Ingelheim and Logic I/S Guerbet SA.

PII: S0002-8703(03)00316-8

doi: 10.1016/S0002-8703(03)00316-8

American Heart Journal
Volume 146, Issue 2 , Pages 234-241 , August 2003

Article Tools

* Image Usage & Resolution